Platencin (CAS 869898-86-2)

Platencin, a natural product derived from Streptomyces platensis, has emerged as a significant compound in scientific research for its potent antibacterial activity and unique mechanism of action. Studies have explaind that Platencin targets bacterial fatty acid synthesis by inhibiting the enzyme FabF, also known as β-ketoacyl-acyl carrier protein synthase II (KAS II), which catalyzes the elongation of fatty acids in the bacterial cell membrane. By disrupting this essential metabolic pathway, Platencin interferes with bacterial membrane integrity and function, ultimately leading to bacterial cell death. Research has further explored the structural features of Platencin and its binding interactions with FabF, providing insights into its mechanism of action and potential for structure-based drug design. Additionally, Platencin has been investigated for its efficacy against various bacterial pathogens, including multidrug-resistant strains, highlighting its potential as a lead compound for the development of novel antibiotics. Furthermore, Platencin has served as a valuable tool in chemical biology research, facilitating the study of fatty acid metabolism and its implications for bacterial physiology and pathogenesis. Overall, Platencin represents a promising candidate for further exploration in antibacterial drug discovery and as a tool for investigating bacterial lipid metabolism.